StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)
September 22, 2026 9:29 AM
UBS analyst Michael Yee reiterated a Buy rating and $320.00 price target on Johnson & Johnson (NYSE: JNJ).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments